Home/Filings/4/0001209191-22-003268
4//SEC Filing

Piekos Brian 4

Accession 0001209191-22-003268

CIK 0001816736other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 9:01 AM ET

Size

5.5 KB

Accession

0001209191-22-003268

Insider Transaction Report

Form 4
Period: 2022-01-13
Piekos Brian
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-01-13+280,876280,876 total
    Common Stock (280,876 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Gemini Therapeutics, Inc. common stock.
  • [F2]These Restricted Stock Units shall vest on the one (1)-year anniversary of the date of grant.

Issuer

Gemini Therapeutics, Inc. /DE

CIK 0001816736

Entity typeother

Related Parties

1
  • filerCIK 0001815308

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 9:01 AM ET
Size
5.5 KB